Alpha 2.0
Login Register
» Articles » PMID: 6423795

Characterization of Aluminum Hydroxide for Use As an Adjuvant in Parenteral Vaccines

Overview
Journal J Parenter Sci Technol
Specialty Pharmacy
Date 1984 Jan 1
PMID 6423795
Citations 6
Authors
S L Hem
J L White
Affiliations
Soon will be listed here.
Citing Articles

Disparate adjuvant properties among three formulations of "alum".

Cain D, Sanders S, Cunningham M, Kelsoe G Vaccine. 2012; 31(4):653-60.

PMID: 23200935 PMC: 3541451. DOI: 10.1016/j.vaccine.2012.11.044.

Influence of protein conformation and adjuvant aggregation on the effectiveness of aluminum hydroxide adjuvant in a model alkaline phosphatase vaccine.

Clausi A, Morin A, Carpenter J, Randolph T J Pharm Sci. 2008; 98(1):114-21.

PMID: 18506831 PMC: 2593119. DOI: 10.1002/jps.21433.

Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum.

Weissburg R, BERMAN P, Cleland J, EASTMAN D, Farina F, Frie S Pharm Res. 1995; 12(10):1439-46.

PMID: 8584477 DOI: 10.1023/a:1016266916893.

Desorption of porcine parvovirus from aluminum hydroxide adjuvant with subsequent viral immunoassay or hemagglutination assay.

Katz J Vet Res Commun. 1987; 11(1):83-92.

PMID: 3033874 DOI: 10.1007/BF00361329.

The pharmacokinetics of, and humoral responses to, antigen delivered by microencapsulated liposomes.

Cohen S, Bernstein H, Hewes C, Chow M, Langer R Proc Natl Acad Sci U S A. 1991; 88(23):10440-4.

PMID: 1961708 PMC: 52944. DOI: 10.1073/pnas.88.23.10440.